16 October, 2026

Singapore
Singapore's Health Sciences Authority accelerates healthcare innovations with new partnerships

The Health Sciences Authority (HSA) in Singapore has announced three initiatives to help promising healthcare innovation...Read more

- 15 October 2026 News

Australia
New Sydney laboratory expands 360biolabs’ Australian network

360biolabs, a BioAgilytix company, has opened a new laboratory in Sydney, bringing its established bioanalytical experti...Read more

- 15 October 2026 News


Middle East countries
Japan's JCR Pharma receives marketing authorisation in Kuwait for Enzyme Replacement Therapy to treat Hunter Syndrome


Japan-based JCR Pharmaceuticals Co., a global specialty biopharmaceutical company dedicated to developing therapies...Read more

- 15 October 2026 News


Taiwan
PurMinds announces clinical validation collaboration with SpectroChip and Kaohsiung Municipal Siaogang Hospital in Taiwan


PurMinds Enterprises, Inc. (formerly Pacific Software, Inc.) has announced the signing of a collaboration agreement with...Read more

- 15 October 2026 News



Korea
Swiss firm Alentis Therapeutics partners with Korea's PinotBio to develop next-gen ADCs targeting claudin-1


Swiss firm Alentis Therapeutics and South Korea based PinotBio have entered into a research collaboration and licensing ...Read more

- 15 October 2026 News





All you want to read on

North America Europe Asia Pacific
South East Asia SAARC Middle East



This email has been sent to you in association with
www.biospectrumasia.com
Tell Us What You Think! Help us improve our newsletters.
Send us your feedback!
© Copyright 2026 MM ACTIV. All rights reserved.
To Unsubscribe click here.

Disclaimer : Please remember – by opting-in you are still able to opt-out at any time, by simply replying to this email at digital@mmactiv.com and typing 'unsubscribe' in the 'subject' field of any future emails. We promise only to send emails that we believe you will find interesting, relevant and current.
Your data will never be sold or shared with any third party, although we may communicate a message to you from a partner that we are in collaboration with.